PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | +215.4% | 13,050 | +180.5% | 0.00% | – |
| Q1 2020 | $13,000 | -13.3% | 4,653 | 0.0% | 0.00% | – |
| Q4 2019 | $15,000 | -93.0% | 4,653 | -95.3% | 0.00% | -100.0% |
| Q3 2019 | $215,000 | +3483.3% | 99,370 | +4868.5% | 0.00% | – |
| Q2 2016 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -90.9% | 2,000 | -83.3% | 0.00% | -100.0% |
| Q2 2015 | $77,000 | -37.4% | 12,000 | -31.4% | 0.00% | -50.0% |
| Q1 2015 | $123,000 | +23.0% | 17,500 | +34.6% | 0.00% | +100.0% |
| Q4 2014 | $100,000 | +3.1% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $97,000 | -56.5% | 13,000 | -43.5% | 0.00% | -66.7% |
| Q2 2014 | $223,000 | -49.3% | 23,000 | -56.6% | 0.00% | -50.0% |
| Q1 2014 | $440,000 | +300.0% | 53,000 | +307.7% | 0.01% | +200.0% |
| Q4 2013 | $110,000 | +37.5% | 13,000 | +30.0% | 0.00% | +100.0% |
| Q3 2013 | $80,000 | -48.1% | 10,000 | -50.0% | 0.00% | -50.0% |
| Q2 2013 | $154,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |